These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3107633)

  • 1. Ultrastructural analysis of human natural killer cell activation.
    Zarcone D; Prasthofer EF; Malavasi F; Pistoia V; LoBuglio AF; Grossi CE
    Blood; 1987 Jun; 69(6):1725-36. PubMed ID: 3107633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes.
    Braakman E; van Tunen A; Meager A; Lucas CJ
    Cell Immunol; 1986 May; 99(2):476-88. PubMed ID: 2944627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2.
    Tompkins MB; Pang VF; Michaely PA; Feinmehl RI; Basgall EJ; Baszler TV; Zachary JF; Tompkins WA
    J Immunol; 1989 Jul; 143(2):749-54. PubMed ID: 2544649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
    Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
    Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking and activation of murine natural killer cells: differing roles for IFN-gamma and IL-2.
    Sayers TJ; Mason LH; Wiltrout TA
    Cell Immunol; 1990 May; 127(2):311-26. PubMed ID: 2109662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI; Brahmi Z
    Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of resting and IL-2 activated NK cells to R-verapamil.
    Markham PN; Ellis TM; Tambur AR; Gebel HM
    Transplantation; 1996 Dec; 62(12):1883-8. PubMed ID: 8990381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
    J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.
    Tarkkanen J; Saksela E
    Infect Immun; 1991 Aug; 59(8):2767-73. PubMed ID: 1713200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2.
    Loughran TP; Draves KE; Starkebaum G; Kidd P; Clark EA
    Blood; 1987 Jan; 69(1):72-8. PubMed ID: 3098327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line.
    Ye J; Ortaldo JR; Conlon K; Winkler-Pickett R; Young HA
    J Leukoc Biol; 1995 Aug; 58(2):225-33. PubMed ID: 7643015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2.
    Scott CF; Lambert JM; Bolender S; Blattler WA
    Cell Immunol; 1988 Jul; 114(2):370-84. PubMed ID: 3260543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.
    Anegón I; Cuturi MC; Trinchieri G; Perussia B
    J Exp Med; 1988 Feb; 167(2):452-72. PubMed ID: 2831292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
    Fitzpatrick L; Makrigiannis AP; Kaiser M; Hoskin DW
    J Interferon Cytokine Res; 1996 Jul; 16(7):537-46. PubMed ID: 8836920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CD2 in regulation of CD3- LGL function.
    Mason A; Bernard A; Smyth MJ; Ortaldo JR
    Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2.
    Koizumi S; Seki H; Tachinami T; Taniguchi M; Matsuda A; Taga K; Nakarai T; Kato E; Taniguchi N; Nakamura H
    Blood; 1986 Nov; 68(5):1065-73. PubMed ID: 2945603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.